Literature DB >> 26295052

Spine and Rheumatic Diseases.

James Cheng-Chung Wei1, Yi Liu2, Hsi-Kai Tsou3, Irene Eva van der Horst-Bruinsma4.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26295052      PMCID： PMC4534749          DOI： 10.1155/2015/756205

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


× No keyword cloud information.
  6 in total

Review 1.  The effectiveness of exercise therapy for ankylosing spondylitis: a review.

Authors:  Ching-Yi Wang; Pin-Yen Chiang; Hong-Shen Lee; James Cheng-Chung Wei
Journal:  Int J Rheum Dis       Date:  2009-09       Impact factor: 2.454

Review 2.  Review: The interleukin-23/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond.

Authors:  Judith A Smith; Robert A Colbert
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

3.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

4.  The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; N Akkoc; J Brandt; C T Chou; M Dougados; F Huang; J Gu; Y Kirazli; F Van den Bosch; I Olivieri; E Roussou; S Scarpato; I J Sørensen; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2010-11-24       Impact factor: 19.103

5.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

Review 6.  Treat-to-target in spondyloarthritis: implications for clinical trial designs.

Authors:  James Cheng-Chung Wei
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.